Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Other acquisition C.E.O. acquired 7,247 shares (code I)
  2. 4 Other acquisition Sr. VP CFO and General Counsel acquired 5,263 shares (code I)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Other acquisition Sr. VP Research & Development acquired 740 shares (code I)
  10. 4 Other acquisition C.E.O. acquired 292 shares (code I)
  11. 4 Other acquisition Sr. VP Finance and CFO acquired 229 shares (code I)
  12. 4 Other acquisition Sr VP & General Counsel acquired 350 shares (code I)
  13. 4 Open-market sale Director sold 12,500 shares at $18.17 ($227,136)
  14. 4 Exercise or conversion Director acquired 65,833 shares (option exercise)
  15. 4 Open-market sale Chief Acct.Officer sold 14,000 shares at $20.70 ($289,800)
  16. 4 Open-market sale Chief Acct.Officer sold 6,831 shares at $20.65 ($141,060)
  17. 4 Open-market sale Chief Acct.Officer sold 40,000 shares at an average $19.94 ($797,502)
  18. 4 Open-market sale Chief Acct.Officer sold 15,000 shares at $19.50 ($292,500)
  19. 4 Open-market sale Director sold 12,500 shares at $16.00 ($200,000)
  20. 4/A Open-market sale Director sold 12,500 shares at an average $15.59 ($194,818)

Page 18 of 23 · 459 filings